| Symbol | TKNO |
|---|---|
| Name | ALPHA TEKNOVA, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Address | 2451 BERT DRIVE, HOLLISTER, California, 95023, United States |
| Telephone | +1 831 637-1100 |
| Fax | — |
| — | |
| Website | https://www.teknova.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001850902 |
| Description | Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Additional info from NASDAQ: |
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
Read moreTeknova to Report Second Quarter 2026 Financial Results on August 5, 2026
Read moreDirector DEMSKI MARTHA J 🟡 adjusted position in 0 shares of Alpha Teknova, Inc. (TKNO) Transaction Date: Jul 14, 2026 | Filing ID: 000007
Read moreDirector Vos Alexander 🟢 acquired 55.0K shares (1 derivative) of Alpha Teknova, Inc. (TKNO) at $5.37 Transaction Date: Jun 01, 2026 | Filing ID: 000002
Read moreDirector ROBERTSON BRETT 🟢 acquired 55.0K shares (1 derivative) of Alpha Teknova, Inc. (TKNO) at $5.37 Transaction Date: Jun 01, 2026 | Filing ID: 000002
Read moreDirector DEMSKI MARTHA J 🟢 acquired 55.0K shares (1 derivative) of Alpha Teknova, Inc. (TKNO) at $5.37 Transaction Date: Jun 01, 2026 | Filing ID: 000005
Read moreNew Form ARS - Alpha Teknova, Inc. <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001193125-26-167275 <b>Size:</b> 719 KB
Read more